These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19834624)

  • 1. The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.
    Legoffic A; Calvo E; Cano C; Folch-Puy E; Barthet M; Delpero JR; Ferrés-Masó M; Dagorn JC; Closa D; Iovanna J
    PLoS One; 2009 Oct; 4(10):e7495. PubMed ID: 19834624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.
    Takehara A; Eguchi H; Ohigashi H; Ishikawa O; Kasugai T; Hosokawa M; Katagiri T; Nakamura Y; Nakagawa H
    Cancer Sci; 2006 Nov; 97(11):1191-7. PubMed ID: 16918991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer.
    Eguchi H; Ishikawa O; Ohigashi H; Takahashi H; Yano M; Nishiyama K; Tomita Y; Uehara R; Takehara A; Nakamura Y; Nakagawa H
    Pancreas; 2009 Oct; 38(7):791-8. PubMed ID: 19546835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
    Takayama R; Nakagawa H; Sawaki A; Mizuno N; Kawai H; Tajika M; Yatabe Y; Matsuo K; Uehara R; Ono K; Nakamura Y; Yamao K
    J Gastroenterol; 2010; 45(1):52-9. PubMed ID: 19789838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
    Rafa L; Dessein AF; Devisme L; Buob D; Truant S; Porchet N; Huet G; Buisine MP; Lesuffleur T
    Int J Oncol; 2010 Mar; 36(3):689-98. PubMed ID: 20126989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H; Camaj P; Renner A; Ischenko I; Zhao Y; Krebs S; Mysliwietz J; Jäckel C; Nelson PJ; Blum H; Jauch KW; Ellwart JW; Bruns CJ
    Target Oncol; 2015 Jun; 10(2):215-27. PubMed ID: 24950733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reg4 protects against acinar cell necrosis in experimental pancreatitis.
    Hu G; Shen J; Cheng L; Guo C; Xu X; Wang F; Huang L; Yang L; He M; Xiang D; Zhu S; Wu M; Yu Y; Han W; Wang X
    Gut; 2011 Jun; 60(6):820-8. PubMed ID: 21193457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
    Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
    BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas.
    Harris JC; Gilliam AD; McKenzie AJ; Evans SA; Grabowska AM; Clarke PA; McWilliams DF; Watson SA
    Cancer Res; 2004 Aug; 64(16):5624-31. PubMed ID: 15313900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9.
    He XJ; Jiang XT; Ma YY; Xia YJ; Wang HJ; Guan TP; Shao QS; Tao HQ
    Cancer Sci; 2012 Dec; 103(12):2082-91. PubMed ID: 22957785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.
    Tang ZY; Wu YL; Gao SL; Shen HW
    J Surg Res; 2008 Mar; 145(1):111-23. PubMed ID: 17714734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
    Wei SH; Dong K; Lin F; Wang X; Li B; Shen JJ; Zhang Q; Wang R; Zhang HZ
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1055-64. PubMed ID: 18297287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array.
    Legoffic A; Calvo EL; Barthet M; Delpero JR; Dagorn JC; Iovanna JL
    Pancreatology; 2009; 9(3):267-72. PubMed ID: 19407481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
    PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
    Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
    Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
    Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
    Zhang J; Jiang H; Mao Z; Wang X; Fan X; Liu Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):335-40. PubMed ID: 25030587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ
    Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.